MedTrace Logo

A Study of the SING IMT in an Israeli Cohort

NCT05941273 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2026-05-18

No results posted yet for this study

Summary

The objective of this single center study is to determine the safety of the smaller incision, new generation (SING), implantable miniature telescope (IMT) in a small sample of patients with moderate-severe central vision loss due to late-stage age-related macular degeneration (AMD) in an Israeli Cohort

Conditions

Interventions

DEVICE

smaller incision, new generation implantable miniature telescope (SING-IMT)

The IMT (model SING) is an intraocular implant comprised of 2 micro lenses in a glass tube (optics) in a flexible silicone carrier (haptics)

Sponsors & Collaborators

  • Wolfson Medical Center

    collaborator OTHER_GOV

  • VisionCare, Inc.

    lead INDUSTRY

Principal Investigators

  • Guy Kleinman, MD · Wolfson Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-30
Primary Completion
2024-01-30
Completion
2026-02-05

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05941273 on ClinicalTrials.gov